Literature DB >> 9720476

The clinical interface of depression and dementia.

M A Raskind1.   

Abstract

The interface between depression and dementia is complex and has been studied primarily in Alzheimer's disease. This article discusses several aspects of this intriguing area of clinical research, including depressive pseudodementia and the possibility that depression may be a risk factor for the expression of Alzheimer's disease in later life and that depression may occur as a prodrome for this most common dementing disorder. In addition, the treatment challenges faced by clinicians when depression complicates the course of Alzheimer's disease are addressed. It is likely that a combination of behavioral treatment and use of antidepressant medication will provide the optimal management of depression in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720476

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

Review 1.  The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden?

Authors:  Daniel L Murman; Christopher C Colenda
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Correlates of dysphoria in Canadian seniors: the Canadian Study of Health and Aging.

Authors:  T Ostbye; R Steenhuis; R Walton; J Cairney
Journal:  Can J Public Health       Date:  2000 Jul-Aug

3.  Poststroke Neuropsychiatric Illness: An Integrated Approach to Diagnosis and Management.

Authors:  James A. Bourgeois; Donald M. Hilty; Celia H. Chang; Mark A. Wineinger; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

4.  Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome.

Authors:  James A Bourgeois; Jennifer B Cogswell; David Hessl; Lin Zhang; Michele Y Ono; Flora Tassone; Faraz Farzin; James A Brunberg; Jim Grigsby; Randi J Hagerman
Journal:  Gen Hosp Psychiatry       Date:  2007 Jul-Aug       Impact factor: 3.238

Review 5.  Depression in nursing homes: ensuring adequate treatment.

Authors:  Robert H Llewellyn-Jones; John Snowdon
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.

Authors:  Paul E Holtzheimer; Thomas W Meeks; Mary E Kelley; Mustafa Mufti; Raymond Young; Kimberly McWhorter; Nancie Vito; Ronald Chismar; Sinéad Quinn; Sherry Dey; Eve H Byrd; William M McDonald
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

7.  Antidepressants for treating depression in dementia.

Authors:  Robert Dudas; Reem Malouf; Jenny McCleery; Tom Dening
Journal:  Cochrane Database Syst Rev       Date:  2018-08-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.